| 07/01/2026 9:20 AM | Nukkleus (1787518) Filer | Form 424B3 | |
| 06/30/2026 11:15 PM | Nukkleus (1787518) Filer | Form EFFECT | |
| 06/29/2026 4:25 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/25/2026 4:11 PM | Nukkleus (1787518) Filer | Form S-1/A | |
| 06/18/2026 4:25 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/15/2026 4:25 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/11/2026 11:55 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/11/2026 11:55 AM | Cohen Roy (2137926) Reporting Nukkleus (1787518) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 06/04/2026 4:30 PM | Nukkleus (1787518) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 05/27/2026 5:07 AM | Nukkleus (1787518) Filer | Form DEF 14A | |
| 05/21/2026 7:01 AM | Nukkleus (1787518) Subject VisionWave Holdings, Inc. (2038439) Filed by | Form SCHEDULE 13G | |
Get the Latest News and Ratings for NUKKW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nukkleus and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/20/2026 4:01 PM | Nukkleus (1787518) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/15/2026 4:25 PM | Nukkleus (1787518) Filer | Form NT 10-Q | |
| 04/28/2026 7:30 AM | Shalom Menachem (2030245) Reporting Nukkleus (1787518) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/28/2026 7:15 AM | Shalom Menachem (2030245) Filed by Nukkleus (1787518) Subject | Form SCHEDULE 13D/A | |
| 04/28/2026 7:05 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/16/2026 3:20 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/15/2026 3:20 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/14/2026 3:05 PM | Nukkleus (1787518) Filer | Form PRE 14A | |
| 04/14/2026 7:00 AM | BiomX Inc. (1739174) Subject Nukkleus (1787518) Filed by | Form SCHEDULE 13D/A | |
| 04/10/2026 2:40 PM | BiomX Inc. (1739174) Subject Nukkleus (1787518) Filed by | Form SCHEDULE 13D | |
| 04/10/2026 11:50 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/09/2026 1:29 PM | Nukkleus (1787518) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 04/07/2026 7:30 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/03/2026 8:09 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/01/2026 7:50 AM | Nukkleus (1787518) Filer | Form 8-K/A | |
| 03/31/2026 3:46 PM | Nukkleus (1787518) Filer | Form NT 10-K | |
| 03/12/2026 10:31 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/06/2026 4:28 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/02/2026 8:12 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/25/2026 10:18 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/20/2026 4:25 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 8:20 PM | Esousa Group Holdings LLC (2033034) Filed by Nukkleus (1787518) Subject | Form SCHEDULE 13G/A | |
| 02/17/2026 7:30 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/16/2026 11:15 PM | Nukkleus (1787518) Filer | Form EFFECT | |
| 02/13/2026 4:21 PM | Nukkleus (1787518) Filer | Form 424B3 | |
| 02/13/2026 5:45 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 3:18 PM | Nukkleus (1787518) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 02/09/2026 7:52 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/03/2026 7:45 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/22/2026 4:01 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Urgent exposé on the "Mar-a-Lago Trade" (Ad) Dr. David Eifrig, former Goldman Sachs VP and Senior Partner at Stansberry Research, has released an urgent exposé on what he calls the $7.2 trillion 'Mar-a-Lago Trade.'
Bloomberg warns it may cause 'a dire shift of fortunes for America.' Eifrig, who called the 2022 crash months early, says this event is already underway and could move as high as 10x from current levels.
Over 500,000 paid subscribers follow his research. Access the full free broadcast before it comes down. Watch Dr. Eifrig's free broadcast and get the full story now |
| 01/20/2026 6:57 PM | Nukkleus (1787518) Issuer Shalom Menachem (2030245) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 6:38 PM | Nukkleus (1787518) Subject Shalom Menachem (2030245) Filed by | Form SCHEDULE 13D | |
| 01/16/2026 7:30 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/14/2026 3:05 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/13/2026 7:30 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/31/2025 4:00 PM | Kotaieva Anastasiia (2045096) Reporting Nukkleus (1787518) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/31/2025 9:10 AM | Kotaieva Anastasiia (2045096) Reporting Nukkleus (1787518) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/30/2025 10:08 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/23/2025 3:50 PM | Nukkleus (1787518) Filer | Form 424B3 | |
| 12/23/2025 3:50 PM | Nukkleus (1787518) Filer | Form 424B3 | |
| 12/22/2025 3:15 PM | Kotaieva Anastasiia (2045096) Reporting Nukkleus (1787518) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 4:19 PM | Nukkleus (1787518) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 12/17/2025 4:19 PM | Nukkleus (1787518) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 12/17/2025 4:27 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/17/2025 3:01 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/11/2025 8:23 AM | Nukkleus (1787518) Filer | Form DEFA14A | |
| 12/09/2025 3:30 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/01/2025 4:20 PM | Nukkleus Defense Technologies, Inc. (2095058) Reporting Nukkleus (1787518) Reporting SC Capital II Sponsor LLC (2076738) Reporting SC II Acquisition Corp. (2076739) Issuer SC II Acquisition Corp. (2076739) Issuer Shalom Menachem (2030245) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/28/2025 12:05 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/26/2025 8:00 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/25/2025 7:37 PM | Nukkleus Defense Technologies, Inc. (2095058) Reporting Nukkleus (1787518) Reporting SC Capital II Sponsor LLC (2076738) Reporting SC II Acquisition Corp. (2076739) Issuer SC II Acquisition Corp. (2076739) Issuer Shalom Menachem (2030245) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 11/25/2025 4:25 PM | Nukkleus (1787518) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 11/25/2025 4:28 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/25/2025 8:28 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/25/2025 8:06 AM | Nukkleus (1787518) Filer | Form DEF 14A | |
| 11/20/2025 1:26 PM | Nukkleus (1787518) Issuer Volodarsky Aviya (2045038) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/20/2025 1:27 PM | Nukkleus (1787518) Issuer Rokach David (2044737) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/20/2025 1:27 PM | Nukkleus (1787518) Issuer Yeganeh Reuven (2044677) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/20/2025 1:27 PM | Nagar Tomer (2050376) Reporting Nukkleus (1787518) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 4:29 PM | Nukkleus (1787518) Issuer Shalom Menachem (2030245) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/14/2025 4:05 PM | Nukkleus (1787518) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/14/2025 3:05 PM | Esousa Group Holdings LLC (2033034) Filed by Nukkleus (1787518) Subject | Form SCHEDULE 13G/A | |
| 11/10/2025 4:29 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/28/2025 4:29 PM | Nukkleus (1787518) Filer | Form PRER14A | |
| 10/24/2025 3:15 PM | Kotaieva Anastasiia (2045096) Reporting Nukkleus (1787518) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/17/2025 8:21 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/16/2025 3:50 PM | Nukkleus (1787518) Filer | Form DEF 14A | |
| 10/10/2025 6:05 PM | Kotaieva Anastasiia (2045096) Reporting Nukkleus (1787518) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/29/2025 8:29 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/19/2025 8:30 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/18/2025 4:27 PM | Nukkleus (1787518) Filer | Form D Notice of Exempt Offering of Securities | |
| 09/16/2025 8:29 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/15/2025 3:23 PM | Nukkleus (1787518) Filer | Form RW | |
| 09/02/2025 4:27 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/02/2025 7:39 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/29/2025 7:13 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/25/2025 3:05 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2025 4:05 PM | Nukkleus (1787518) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/08/2025 7:00 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/31/2025 8:12 AM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Do NOT Buy SpaceX – Do This Instead (Ad) SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors.
Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now. Read Tilson's free analysis and find out what to do with your money |
| 07/29/2025 4:17 PM | Nukkleus (1787518) Filer | Form PRER14A | |
| 07/29/2025 4:27 PM | Nukkleus (1787518) Filer | Form S-1/A | |
| 07/25/2025 3:01 PM | Nukkleus (1787518) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/15/2025 7:34 AM | Esousa Group Holdings LLC (2033034) Filed by Nukkleus (1787518) Subject | Form SCHEDULE 13G/A | |